Novo Holdings is the holding and investment company of the Novo Nordisk Foundation. It manages the assets and wealth of the Foundation and serves as the controlling shareholder of Novo Nordisk and Novonesis (the Novo Group). The company aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the Foundation’s assets.
Novo Holdings invests in life science companies at all stages of development. Beyond life science investments, it also manages a broad portfolio spanning equities, bonds, real estate, infrastructure assets, and private equity. The organization operates from offices in Copenhagen, London, San Francisco, Boston, Singapore, Shanghai, and Mumbai, and describes a culture centered on high performance alongside respect and responsibility.
